| Toward minimal residual disease-directed therapy in melanoma F Rambow, A Rogiers, O Marin-Bejar, S Aibar, J Femel, M Dewaele, ... Cell 174 (4), 843-855. e19, 2018 | 599 | 2018 |
| Melanoma addiction to the long non-coding RNA SAMMSON E Leucci, R Vendramin, M Spinazzi, P Laurette, M Fiers, J Wouters, ... Nature 531 (7595), 518-522, 2016 | 553 | 2016 |
| Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study A Fendler, STC Shepherd, L Au, KA Wilkinson, M Wu, F Byrne, M Cerrone, ... Nature cancer 2 (12), 1305-1320, 2021 | 167 | 2021 |
| Antisense oligonucleotide–mediated MDM4 exon 6 skipping impairs tumor growth M Dewaele, T Tabaglio, K Willekens, M Bezzi, SX Teo, DHP Low, CM Koh, ... The Journal of clinical investigation 126 (1), 68-84, 2016 | 167 | 2016 |
| Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia CC Bell, KA Fennell, YC Chan, F Rambow, MM Yeung, D Vassiliadis, ... Nature communications 10 (1), 2723, 2019 | 152 | 2019 |
| Sustained SREBP-1-dependent lipogenesis as a key mediator of resistance to BRAF-targeted therapy A Talebi, J Dehairs, F Rambow, A Rogiers, D Nittner, R Derua, ... Nature communications 9 (1), 2500, 2018 | 118 | 2018 |
| The characteristics of 76 atypical neurofibromas as precursors to neurofibromatosis 1 associated malignant peripheral nerve sheath tumors CS Higham, E Dombi, A Rogiers, S Bhaumik, S Pans, SEJ Connor, ... Neuro-oncology 20 (6), 818-825, 2018 | 109 | 2018 |
| Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma O Marin-Bejar, A Rogiers, M Dewaele, J Femel, P Karras, J Pozniak, ... Cancer Cell 39 (8), 1135-1149. e8, 2021 | 96 | 2021 |
| Sustained activation of the Aryl hydrocarbon Receptor transcription factor promotes resistance to BRAF-inhibitors in melanoma S Corre, N Tardif, N Mouchet, HM Leclair, L Boussemart, A Gautron, ... Nature communications 9 (1), 4775, 2018 | 91 | 2018 |
| A non-coding function of TYRP1 mRNA promotes melanoma growth D Gilot, M Migault, L Bachelot, F Journé, A Rogiers, E Donnou-Fournet, ... Nature cell biology 19 (11), 1348-1357, 2017 | 87 | 2017 |
| Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer A Fendler, STC Shepherd, L Au, M Wu, R Harvey, AM Schmitt, Z Tippu, ... The Lancet 399 (10328), 905-907, 2022 | 77 | 2022 |
| Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer A Fendler, STC Shepherd, L Au, KA Wilkinson, M Wu, AM Schmitt, Z Tippu, ... Cancer Cell 40 (2), 114-116, 2022 | 67 | 2022 |
| Calcitonin gene-related peptide8-37 antagonizes capsaicin-induced vasodilation in the skin: evaluation of a human in vivo pharmacodynamic model BJ Van der Schueren, A Rogiers, FH Vanmolkot, A Van Hecken, M Depre, ... Journal of Pharmacology and Experimental Therapeutics 325 (1), 248-255, 2008 | 64 | 2008 |
| Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition A Rogiers, IP Da Silva, C Tentori, CA Tondini, JM Grimes, MH Trager, ... Journal for ImmunoTherapy of Cancer 9 (1), 2021 | 61 | 2021 |
| Shrinkage of thyroid volume in sunitinib-treated patients with renal-cell carcinoma: a potential marker of irreversible thyroid dysfunction? A Rogiers, P Wolter, KO de Beeck, M Thijs, B Decallonne, P Schöffski Thyroid 20 (3), 317-322, 2010 | 52 | 2010 |
| Molecular genetic and immunotherapeutic targets in metastatic melanoma C Melis, A Rogiers, O Bechter, JJ van den Oord Virchows Archiv 471, 281-293, 2017 | 25 | 2017 |
| Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer A Fendler, STC Shepherd, L Au, M Wu, R Harvey, KA Wilkinson, ... Cell Reports Medicine 3 (10), 2022 | 23 | 2022 |
| Dabrafenib plus trametinib rechallenge in four melanoma patients who previously progressed on this combination A Rogiers, P Wolter, O Bechter Melanoma research 27 (2), 164-167, 2017 | 23 | 2017 |
| Late-stage metastatic melanoma emerges through a diversity of evolutionary pathways L Spain, A Coulton, I Lobon, A Rowan, D Schnidrig, STC Shepherd, ... Cancer discovery 13 (6), 1364-1385, 2023 | 19 | 2023 |
| The efficacy of immune checkpoint blockade for melanoma in-transit with or without nodal metastases–A multicenter cohort study CJ Holmberg, L Ny, TJ Hieken, MS Block, MJ Carr, VK Sondak, ... European Journal of Cancer 169, 210-222, 2022 | 16 | 2022 |
Eleonora LeucciKU Leuven在 kuleuven.be 的电子邮件经过验证
